Codes ATC:
L01EA02
EMLc
Indication
Chronic myeloid leukaemia, not elsewhere classified
Code ICD11:
2C03.2
INN
Dasatinib
Type de médicament
Chemical agent
Type de liste
Liste complémentaire
(EML)
(EMLc)
(EMLc)
Additional notes
Imatinib-resistant chronic myeloid leukaemia
Formulations
Oral > Solid:
20 mg tablet ;
50 mg tablet ;
70 mg tablet ;
80 mg tablet ;
100 mg tablet (EML)
;
140 mg tablet (EML)
Historique des statuts LME
Sexe
Tous
Âge
Aussi recommandé pour les enfants
Équivalence thérapeutique
La recommandation concerne ce médicament spécifique
Renseignements sur le brevet
Main patent is active in several jurisdictions. For more information on specific patents and
license status for developing countries visit www.MedsPal.org
Lire la suite
sur les brevets.
Résumé des preuves et recommandation du comité d'experts
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended deletion of dasatinib 100 mg and 140 mg tablets from the EMLc.